430 related articles for article (PubMed ID: 29277511)
1. Health Insurance and the Use of Peritoneal Dialysis in the United States.
Perez JJ; Zhao B; Qureshi S; Winkelmayer WC; Erickson KF
Am J Kidney Dis; 2018 Apr; 71(4):479-487. PubMed ID: 29277511
[TBL] [Abstract][Full Text] [Related]
2. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access.
Lin E; Mell MW; Winkelmayer WC; Erickson KF
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1866-1875. PubMed ID: 30385594
[TBL] [Abstract][Full Text] [Related]
3. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
[TBL] [Abstract][Full Text] [Related]
4. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
5. Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.
Turenne M; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Cope E
Health Serv Res; 2018 Jun; 53(3):1430-1457. PubMed ID: 28560726
[TBL] [Abstract][Full Text] [Related]
6. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
7. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
Devlin A; Waikar SS; Solomon DH; Lu B; Shaykevich T; Alarcón GS; Winkelmayer WC; Costenbader KH
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1642-53. PubMed ID: 22058067
[TBL] [Abstract][Full Text] [Related]
8. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
[TBL] [Abstract][Full Text] [Related]
10. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.
Weinhandl ED; Gilbertson DT; Collins AJ
Am J Kidney Dis; 2016 Jan; 67(1):98-110. PubMed ID: 26319755
[TBL] [Abstract][Full Text] [Related]
11. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
[TBL] [Abstract][Full Text] [Related]
12. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
13. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.
Niu J; Shah MK; Perez JJ; Airy M; Navaneethan SD; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2019 Mar; 73(3):324-331. PubMed ID: 30449517
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
15. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
[TBL] [Abstract][Full Text] [Related]
16. Unequal access to cadaveric kidney transplantation in California based on insurance status.
Thamer M; Henderson SC; Ray NF; Rinehart CS; Greer JW; Danovitch GM
Health Serv Res; 1999 Oct; 34(4):879-900. PubMed ID: 10536975
[TBL] [Abstract][Full Text] [Related]
17. Transfers to Hemodialysis Among US Patients Initiating Renal Replacement Therapy With Peritoneal Dialysis.
McGill RL; Weiner DE; Ruthazer R; Miskulin DC; Meyer KB; Lacson E
Am J Kidney Dis; 2019 Nov; 74(5):620-628. PubMed ID: 31301926
[TBL] [Abstract][Full Text] [Related]
18. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
19. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
[TBL] [Abstract][Full Text] [Related]
20. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
